XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities    
Net loss $ (4,305,931) $ (4,929,030)
Adjustments to reconcile net loss to cash used in operating activities    
Depreciation, amortization and accretion 2,092,618 869,312
Stock-based compensation expense 454,918 165,171
Loss (gain) from change in fair value of contingent consideration (99,895) 0
Loss on sale of equipment 112,110 0
Gain on termination of lease (343,185) 0
Changes in allowance for bad debt 408 0
Loss (gain) from change in fair value of CVR 97,559 0
Derivative income 0 (1,830)
Changes in operating assets and liabilities:    
(Increase) decrease in accounts receivable (928,895) 35,359
(Increase) decrease in inventory (1,480,116) 59,340
Decrease in prepaid expenses and other 2,027,358 384,582
(Increase) in other current assets (237,720) 0
(Decrease) increase in accounts payable and other (4,519,601) 276,917
Increase in accrued liabilities 412,328 3,441
(Decrease) increase in accrued compensation (1,150,142) 152,911
(Decrease) in contract liabilities (106,760) 0
(Decrease) in deferred rent 0 (3,990)
Net cash used in operating activities (7,974,946) (2,987,817)
Cash flows used in investing activities    
Deposit 2,200 0
Contingent consideration payment (19,140) (42,103)
Note receivable 0 (1,000,000)
Net cash used in investing activities (16,940) (1,042,103)
Cash flows from financing activities    
Issuance cost related to registered offering (1,632,727) 0
Payments made to borrowings (136,364) 0
Payments made to fixed payment arrangements (409,487) 0
Net cash used by financing activities (2,178,578) 0
Net change in cash, restricted cash and cash equivalents (10,170,464) (4,029,920)
Cash, restricted cash and cash equivalents at beginning of period 48,333,307 11,294,227
Cash, restricted cash and cash equivalents at end of period 38,162,843 7,264,307
Supplemental disclosures of cash and non-cash investing and financing transactions    
Warrants issued to underwriters 356,139 0
Cash paid for interest 247,869 3,390
Fair value of right-to-use asset and related lease liability 20,438 412,691
Contingent consideration included in accounts payable 0 3,430
Fixed payment arrangements included in accrued liabilities 430,510 0
Acquisition costs included in accounts payable 0 59,014
Exchange of convertible preferred stock into common stock $ 0 $ 44